In recently published work, the researchers combined RNA-seq, proteomics, and metabolomics to study mechanisms of action of the chemotherapeutic cisplatin.
Researchers find that molecular traces obtained from people's phones can give a glimpse into their lifestyle, the Huffington Post reports.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
Scientists from Kyoto University designed reagents that labeled proteins only in the presence of zinc ions for later analysis by mass spec.
The researchers said the bones likely belonged to individuals who were among the latest Neanderthals in Western Europe.
US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.
The communication concerns a software defect that can cause several of the company's mass spectrometry instruments to incorrectly assign results to samples.
Researchers also uncovered key pathways and alterations linked to differences in survival.
The WUSTL-developed method detects a bile acid that is found at increased levels in Niemann-Pick patients, and is ready for pilot testing, its developers said.
The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.